T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Teva Pharmaceuticals
TEVA
$42.6B
| $398M | 0.09% |
7,056,910
-469,554
| -6% | -$30.4M |
|
|
ATHN
252
DELISTED
Athenahealth, Inc.
ATHN
| $395M | 0.09% |
2,963,484
+582,445
| +24% | +$76M |
|
253
Seagate
STX
$209B
| $394M | 0.09% |
8,794,386
+1,295,406
| +17% | +$62.7M |
|
254
Jones Lang LaSalle
JLL
$17B
| $393M | 0.09% |
2,736,500
-312,728
| -10% | -$51.1M |
|
255
Intel
INTC
$527B
| $390M | 0.09% |
12,931,880
+222,670
| +2% | +$6.44M |
|
256
JB Hunt Transport Services
JBHT
$26.5B
| $389M | 0.09% |
5,455,131
-1,615,149
| -23% | -$128M |
|
257
Zillow
Z
$8.08B
| $389M | 0.09% |
+14,406,800
| New | +$376M |
|
258
DexCom
DXCM
$34.5B
| $383M | 0.09% |
17,852,332
-2,035,328
| -10% | -$45.4M |
|
|
STI
259
DELISTED
SunTrust Banks, Inc.
STI
| $382M | 0.09% |
9,992,922
-4,564,703
| -31% | -$191M |
|
|
CLGX
260
DELISTED
Corelogic, Inc.
CLGX
| $381M | 0.08% |
10,222,859
-1,238,802
| -11% | -$48.1M |
|
|
KSU
261
DELISTED
Kansas City Southern
KSU
| $381M | 0.08% |
4,187,742
-278,791
| -6% | -$26.3M |
|
|
MIK
262
DELISTED
Michaels Stores, Inc
MIK
| $379M | 0.08% |
16,403,750
+4,563,120
| +39% | +$116M |
|
263
Clorox
CLX
$12.9B
| $378M | 0.08% |
3,270,360
-859,610
| -21% | -$96.5M |
|
264
Revvity
RVTY
$13.1B
| $372M | 0.08% |
8,091,431
+3,016,975
| +59% | +$150M |
|
265
Conagra Brands
CAG
$7.39B
| $372M | 0.08% |
11,794,187
-1,776,603
| -13% | -$59.6M |
|
266
Essex Property Trust
ESS
$18.5B
| $363M | 0.08% |
1,626,124
-13,391
| -0.8% | -$2.95M |
|
267
Federal Realty Investment Trust
FRT
$10.3B
| $363M | 0.08% |
2,662,350
-2,730
| -0.1% | -$365K |
|
268
Corning
GLW
$137B
| $359M | 0.08% |
20,960,867
+81,194
| +0.4% | +$1.46M |
|
|
VIAB
269
DELISTED
Viacom Inc. Class B
VIAB
| $356M | 0.08% |
8,255,239
+796,075
| +11% | +$39.4M |
|
270
McCormick & Company Non-Voting
MKC
$14.6B
| $354M | 0.08% |
8,618,440
-239,946
| -3% | -$9.75M |
|
271
Equity Residential
EQR
$24.7B
| $353M | 0.08% |
4,699,264
+13,438
| +0.3% | +$988K |
|
272
Viatris
VTRS
$18.4B
| $350M | 0.08% |
8,688,828
+3,045,633
| +54% | +$170M |
|
273
Neurocrine Biosciences
NBIX
$15.3B
| $349M | 0.08% |
8,770,009
-1,023,730
| -10% | -$49.5M |
|
274
NETSCOUT
NTCT
$2.89B
| $348M | 0.08% |
9,829,490
+9,570,990
| +3,703% | +$362M |
|
275
Aptiv
APTV
$10.2B
| $346M | 0.08% |
4,547,775
-621,156
| -12% | -$47.7M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.